Know about Irritable Bowel Syndrome & Inflammatory Bowel Disease.
What is the difference between IBS & IBD?
IBS - Irritable Bowel Syndrome and IBD - Inflammatory Bowel Disease, are two conditions of the intestinal tract. They share some common symptoms such as pain and discomfort, urgency and bloating, and alteration of bowel habits. However, while Irritable Bowel Syndrome IBS is usually characterized as a functional disease or syndrome with a diagnosis made on a cluster of symptoms in the absence of notable structural abnormalities, Inflammatory Bowel Disease IBD, on the other hand, does differ in that it is a collection of disorders characterized by chronic mucosal and/or inflammation of the intestines.
Probiotics may beneficially affect both Irritable Bowel Syndrome IBS & Inflammatory Bowel Disease IBD in the following ways:
- Probiotics assist in decreasing the inflammatory process
- Probiotics reestablish correct gut motility
- Probiotics correct altered gut motility
- Probiotics decrease gaseous bloating due to infections
- Probiotics increase immune response to parasites (infections)
- Probiotics exclude parasites and pathogens
It is easy to see how Probiotic therapy is at the advent of natural approaches to digestive conditions.
Hyperacidity is characteristic of overgrowth of pathogenic bacteria in the digestive tract which may be associated with both Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). Regular use of a simple home Litmus paper test will help you assess and adjust your acid/alkaline balance.
A simple home stool test can assist in accurately distinguishing between Irritable Bowel Syndrome IBS and Infammatory Bowel Disease IBD. See Genova CDSA and Parasitology 2.0
Irritable Bowel Syndrome (IBS) is alternately known as spastic colon, spastic colitis, mucous colitis, nervous stomach and nervous diarrhea. Irritable bowel syndrome (IBS) is the number one digestive disease in America with 30-50 million sufferers.
Inflammatory Bowel Disease IBD is typically separated into two different diseases - Crohn's Disease and Ulcerative Colitis. IBD is characterized by inflammation or ulceration, i.e. "organic" changes in the small and/or large intestines, which are not associated with IBS.
Crohn's Disease is characterized by inflammation involving all layers of the bowel wall in any part of the gastro-intestinal tract. The most common sites include the small intestine, colon, and stomach. Abdominal pain is common and may be mistaken for acute appendicitis. Stools are often non-bloody. The distal colon is not involved. Weight loss and fever are common. Occasionally, an inflamed tender loop of small bowel may be felt on a physical examination.
Ulcerative Colitis is characterized by chronic inflammation of the colon and usually does not involve the small intestine. Typically, the inflammatory process begins at the rectum and spreads. Common sites of involvement include the rectum & recto-sigmoid area. The rectum is almost always involved and continuous biopsies reveal superficial inflammation.
In Crohn's Disease there is an increased expression of THl cells whereas with Ulcerative Colitis an atypical Th2 response is present. Current medical therapies that target IBD go after various drugs to help decrease inflammation, although it remains unclear as to the triggering factor initiating the inflammatory response.
Irritable Bowel Syndrome (IBS) shows no physical evidence of its presence on exam by blood test or X-ray. The alteration in the functioning of the gastrointestinal tract in Irritable Bowel Syndrome causes malabsorption which may result in chronic inflammation throughout the body. The inflammation may show up in any organ system. ). The inflamed colon of Irritable Bowel Syndrome is not a disease; rather, it's a combination of symptoms that do not currently respond well to medications or surgery.
It has been suggested that psycho-social and physical stressors may lead to the development of Irritable Bowel Syndrome. Continuously eating a diet of junk food and/or experiencing ongoing emotionally stressful social or work-related situations may trigger Irritable Bowel Syndrome IBS. Psychological and alternative medicine therapies have been studied in patients with Irritable Bowel Syndrome IBS. Drosman and Colleges recorded the result of a large and successful multi-center, randomized trial comparing cognitive therapy with education.
In a group with moderate to severe functional bowel disorder. Investigators randomized 215 patients, to either Cognitive Behavior therapy or education. The Cognitive Behavior therapy was significantly more effective than education, with a response rate of 70% compared to 37% respectively.
This application is relevant for children with diseases such as autism or other disease where children are known to have gastro-intestinal disturbances. These results were significant and were confirmed through protocol analysis. The authors concluded that 12 week Cognitive Behavioral therapy was more effective than education, regardless of symptoms or severity. It has also been demonstrated that alterations in the gut immune system are also present in IBS. There is an increase in mast cells in the Ileum and colonic mucosa.
A build-up of toxic material in the GI tract as a result of both IBS and IBD can be potentially dangerous. The effects range from neurological impairment to altered immune and gene function. Additionally, there may be a cross-over role with gut-related adult diseases. The preventive administration of probiotics prevent any recycling of the toxic substances or at least minimize it. As the probiotics contact and process the various substances, undoubtedly some mutations occurs. Therefore, a constant replenishment of probiotics is important. Probiotics provide a unique method of detoxification of the gut both during and after healing.
Not only can the probiotics assist with clearance of foreign matter, but they also aid in a number of other important processes such as re-establishing a correct bacterial population ratio between the various parts of the GI tract.